Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sholl
    Junior Member
    • Aug 2020
    • 0

    Announcing the Genetic Engineering Attribution Challenge!

    altLabs is excited to announce the launch of our new data science competition Genetic Engineering Attribution Challenge! We’re awarding $60,000 in prizes for improved and inventive solutions to a crucial problem in genetic engineering: where was this engineered?

    Identifying the designer of genetically engineered DNA is a crucial capability for the maturation of genetic engineering as a field, with important applications in academia, industry, and forensics. By connecting a genetically engineered system with its designers, we can promote responsible innovation in synthetic biology – without stifling innovation. In this competition, we challenge you to join us in advancing the state of the art.

    Teams will compete to predict the labs-of-origin for a dataset of engineered sequences. Prizes will go to the teams who achieve the highest prediction accuracy, and to those who best demonstrate creative applications of their approach to real-world attribution problems.

    We’re searching for creative and original solutions from across fields, and are especially excited to see collaborations across disciplines. Whether your background is in bioinformatics, data science, or something else, we’re calling on you to compete!

    The first stage of the competition is now live, with submissions due by October 19th at 23:59 UTC. To learn more, find a team, and get involved, click here!

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2



    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    Introduction

    The systematic characterization
    ...
    Today, 10:07 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 11:10 AM
0 responses
5 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...